ID   C108 [Mouse lung carcinoma]
AC   CVCL_3986
SY   C 108
DR   BTO; BTO_0000587
DR   CLO; CLO_0002068
DR   CLDB; cl519
DR   Wikidata; Q54807831
RX   PubMed=543011;
RX   PubMed=6085723;
RX   PubMed=6203864;
RX   PubMed=6480290;
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21769; Malignant tumors of the mouse pulmonary system
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_5653 ! 3LL
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 11
//
RX   PubMed=543011; DOI=10.1177/030089167906500601;
RA   Sacchi A., Corsi A., Caputo M., Zupi G.;
RT   "In vitro and in vivo selection of two Lewis lung carcinoma cell
RT   lines.";
RL   Tumori 65:657-664(1979).
//
RX   PubMed=6085723; DOI=10.1007/BF00052417;
RA   Sacchi A., Mauro F., Zupi G.;
RT   "Changes of phenotypic characteristics of variants derived from Lewis
RT   lung carcinoma during long-term in vitro growth.";
RL   Clin. Exp. Metastasis 2:171-178(1984).
//
RX   PubMed=6203864;
RA   Sacchi A., Calabresi F., Greco C., Zupi G.;
RT   "Different metastatic potential of in vitro and in vivo lines selected
RT   from Lewis lung carcinoma: correlation with response to different
RT   bleomycin schedulings.";
RL   Invasion Metastasis 1:227-238(1981).
//
RX   PubMed=6480290;
RA   Zupi G., Corsi A., Sacchi A., Lassiani L., Giraldi T.;
RT   "Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor
RT   lines with different metastatic capacity.";
RL   Invasion Metastasis 4:179-188(1984).
//